131 related articles for article (PubMed ID: 37742062)
1. Coculturing liver cancer cells and monocytes in spheroids conditions monocytes to adopt tumor-associated macrophage phenotypes that favor tumor growth via cholesterol metabolism.
Keawvilai P; Kueanjinda P; Klomsing J; Palaga T
J Leukoc Biol; 2024 Jan; 115(2):344-357. PubMed ID: 37742062
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors.
Yang Y; Ye YC; Chen Y; Zhao JL; Gao CC; Han H; Liu WC; Qin HY
Cell Death Dis; 2018 Jul; 9(8):793. PubMed ID: 30022048
[TBL] [Abstract][Full Text] [Related]
3. Cancer‑associated fibroblast‑induced M2‑polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor‑1 pathway.
Chen S; Morine Y; Tokuda K; Yamada S; Saito Y; Nishi M; Ikemoto T; Shimada M
Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195849
[TBL] [Abstract][Full Text] [Related]
4. Construction of TME and Identification of crosstalk between malignant cells and macrophages by SPP1 in hepatocellular carcinoma.
Liu L; Zhang R; Deng J; Dai X; Zhu X; Fu Q; Zhang H; Tong Z; Zhao P; Fang W; Zheng Y; Bao X
Cancer Immunol Immunother; 2022 Jan; 71(1):121-136. PubMed ID: 34028567
[TBL] [Abstract][Full Text] [Related]
5. TRIM65 knockout inhibits the development of HCC by polarization tumor-associated macrophages towards M1 phenotype via JAK1/STAT1 signaling pathway.
Jiang M; Wang D; Su N; Lou W; Chen Y; Yang H; Chen C; Xi F; Chen Y; Deng L; Tang X
Int Immunopharmacol; 2024 Feb; 128():111494. PubMed ID: 38218012
[TBL] [Abstract][Full Text] [Related]
6. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX
Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648
[TBL] [Abstract][Full Text] [Related]
7. TMEM147 aggravates the progression of HCC by modulating cholesterol homeostasis, suppressing ferroptosis, and promoting the M2 polarization of tumor-associated macrophages.
Huang J; Pan H; Sun J; Wu J; Xuan Q; Wang J; Ke S; Lu S; Li Z; Feng Z; Hua Y; Yu Q; Yin B; Qian B; Zhou M; Xu Y; Bai M; Zhang Y; Wu Y; Ma Y; Jiang H; Dai W
J Exp Clin Cancer Res; 2023 Oct; 42(1):286. PubMed ID: 37891677
[TBL] [Abstract][Full Text] [Related]
8. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
[TBL] [Abstract][Full Text] [Related]
9. Nogo-B fosters HCC progression by enhancing Yap/Taz-mediated tumor-associated macrophages M2 polarization.
Zhao X; Wang X; You Y; Wen D; Feng Z; Zhou Y; Que K; Gong J; Liu Z
Exp Cell Res; 2020 Jun; 391(1):111979. PubMed ID: 32246992
[TBL] [Abstract][Full Text] [Related]
10. Arenobufagin modulation of PCSK9-mediated cholesterol metabolism induces tumor-associated macrophages polarisation to inhibit hepatocellular carcinoma progression.
Li Y; Chen Y; Zhao C; Yang Y; Zhang M; Cheng H; Li Q; Wang M
Phytomedicine; 2024 Jun; 128():155532. PubMed ID: 38493722
[TBL] [Abstract][Full Text] [Related]
11. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis.
Jiang Y; Han Q; Zhao H; Zhang J
J Exp Clin Cancer Res; 2021 Jan; 40(1):13. PubMed ID: 33407720
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma.
Sung PS
Clin Mol Hepatol; 2022 Jul; 28(3):333-350. PubMed ID: 34665953
[TBL] [Abstract][Full Text] [Related]
13. Tumor cell SPTBN1 inhibits M2 polarization of macrophages by suppressing CXCL1 expression.
Wu H; Jiang N; Li J; Jin Q; Jin J; Guo J; Wei X; Wang X; Yao L; Meng D; Zhi X
J Cell Physiol; 2024 Jan; 239(1):97-111. PubMed ID: 37921259
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the Histone Methyltransferase EZH2 Enhances Protumor Monocyte Recruitment in Human Mesothelioma Spheroids.
Mola S; Pinton G; Erreni M; Corazzari M; De Andrea M; Grolla AA; Martini V; Moro L; Porta C
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922336
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of HMGB1 inhibits the crosstalk between oral squamous cell carcinoma cells and tumor-associated macrophages.
Wen J; Yin P; Su Y; Gao F; Wu Y; Zhang W; Chi P; Chen J; Zhang X
Int Immunopharmacol; 2023 Jun; 119():110259. PubMed ID: 37141670
[TBL] [Abstract][Full Text] [Related]
16. Tumor-derived adenosine promotes macrophage proliferation in human hepatocellular carcinoma.
Wang J; Wang Y; Chu Y; Li Z; Yu X; Huang Z; Xu J; Zheng L
J Hepatol; 2021 Mar; 74(3):627-637. PubMed ID: 33137360
[TBL] [Abstract][Full Text] [Related]
17. Reciprocal interactions between malignant cells and macrophages enhance cancer stemness and M2 polarization in HBV-associated hepatocellular carcinoma.
Zhang Q; Tsui YM; Zhang VX; Lu AJ; Lee JM; Lee E; Cheung GC; Li PM; Cheung ET; Chia NH; Lo IL; Chan AC; Cheung TT; Ng IO; Ho DW
Theranostics; 2024; 14(2):892-910. PubMed ID: 38169544
[No Abstract] [Full Text] [Related]
18. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
19. Tumor-associated macrophages induced spheroid formation by CCL18-ZEB1-M-CSF feedback loop to promote transcoelomic metastasis of ovarian cancer.
Long L; Hu Y; Long T; Lu X; Tuo Y; Li Y; Ke Z
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34969774
[TBL] [Abstract][Full Text] [Related]
20. Targeting of Annexin A1 in Tumor-associated Macrophages as a therapeutic strategy for hepatocellular carcinoma.
Song Z; Wang X; Liu X; Luo Y; Qiu J; Yin A; Liu Y; Yi H; Xiao Z; Li A
Biochem Pharmacol; 2023 Jul; 213():115612. PubMed ID: 37209858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]